Screening for acrylate/methacrylate allergy in the baseline series: our experience in Sweden and Singapore
Background: No studies to specifically determine the prevalence of contact allergy to acrylates/methacrylates in patch tested populations have been published. Objectives: To determine the prevalence of acrylate/methacrylate allergy in all patients tested to the baseline patch test series. Methods:...
Saved in:
Published in | Contact dermatitis Vol. 59; no. 5; pp. 307 - 313 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.11.2008
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background: No studies to specifically determine the prevalence of contact allergy to acrylates/methacrylates in patch tested populations have been published.
Objectives: To determine the prevalence of acrylate/methacrylate allergy in all patients tested to the baseline patch test series.
Methods: Five acrylate/methacrylate allergens (2‐hydroxyethyl methacrylate, methyl methacrylate, ethylene glycol dimethacrylate, triethylene glycol diacrylate, and 2‐hydroxypropyl acrylate) were included in the baseline series for at least 2 years in Malmö and Singapore.
Results: Thirty‐eight patients in total had reacted to acrylate/methacrylate allergens in the baseline series during the study period in both populations. In Malmö, there were 26 (1.4%) patients with positive patch tests to acrylate/methacrylate allergens, 14 of whom had relevant reactions. In Singapore, there were 12 (1.0%) patients with positive patch tests to acrylate/methacrylate allergens, but only 1 had relevant reactions. If we had not added acrylate/methacrylate allergens to the baseline series, we would not have patch tested 13/26 (50%) of the positive reactors in Malmö and 11/12 (92%) of the positive reactors in Singapore. The overall proportion of missed positive reactors would have been 24/38 (63%).
Conclusions: The prevalence of acrylate/methacrylate allergy in our patch tested dermatitis populations is 1.4% in Malmö and 1.0% in Singapore. |
---|---|
Bibliography: | ArticleID:COD1440 istex:5785AB42947FFF5135A3C6BAA7DDECDE202C6936 ark:/67375/WNG-8QW7TP4N-8 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0105-1873 1600-0536 |
DOI: | 10.1111/j.1600-0536.2008.01440.x |